Željko Reiner

机构：University Hospital Centre Zagreb, University of Zagreb, Hypertension Institute, Polish Mother’s Memorial Hospital Research Institute

发表论文 54 篇 · 总被引 10866 次 · h-index 18

代表论文

• 2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP) (2024 · Drugs · 被引 56)
• Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Increases Antioxidative Capacity and Improves Renal Function in Diabetic Rats (2023 · Journal of Clinical Medicine · 被引 33)
• PCSK9 inhibition: from effectiveness to cost-effectiveness (2024 · Frontiers in Cardiovascular Medicine · 被引 30)
• Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation (2024 · European Heart Journal - Cardiovascular Pharmacotherapy · 被引 24)
• Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry (2024 · European Heart Journal · 被引 23)
• Effect of Statins on Serum Levels of TNF-alpha and Interleukin-6 in Patients with Kidney Disease: A Meta-analysis of Randomized Clinical Trials (2024 · Current Pharmaceutical Design · 被引 7)